ArticleEuropean journal of nuclear medicine and molecular imaging2022

A self-triggered radioligand therapy agent for fluorescence imaging of the treatment response in prostate cancer.

Hongchuang Xu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.